Estimated global incidence of Japanese encephalitis: a systematic review

被引:932
作者
Campbell, Grant L. [2 ]
Hills, Susan L. [3 ]
Fischer, Marc [3 ]
Jacobson, Julie A. [4 ]
Hoke, Charles H. [5 ]
Hombach, Joachim M. [6 ]
Marfin, Anthony A. [7 ]
Solomon, Tom [8 ]
Tsai, Theodore F. [9 ]
Tsu, Vivien D. [1 ]
Ginsburg, Amy S. [1 ]
机构
[1] PATH, Seattle, WA USA
[2] Ross River Consulting, La Porte, IN USA
[3] Ctr Dis Control & Prevent, Ft Collins, CO USA
[4] Bill & Melinda Gates Fdn, Seattle, WA USA
[5] US Army Med Mat Dev Act, Pharmaceut Syst Project Management Off, Ft Detrick, MD USA
[6] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland
[7] Washington State Dept Hlth, Shoreline, WA USA
[8] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England
[9] Novartis Vaccines, Sci Affairs, Cambridge, MA USA
关键词
CLINICAL-FEATURES; CHILDREN YOUNGER; SURVEILLANCE; DISEASE; BURDEN; IMMUNIZATION; AUSTRALIA; SHANGHAI; OUTBREAK; MALAYSIA;
D O I
10.2471/BLT.10.085233
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Objective To update the estimated global incidence of Japanese encephalitis (JE) using recent data for the purpose of guiding prevention and control efforts. Methods Thirty-two areas endemic for JE in 24 Asian and Western Pacific countries were sorted into 10 incidence groups on the basis of published data and expert opinion. Population-based surveillance studies using laboratory-confirmed cases were sought for each incidence group by a computerized search of the scientific literature. When no eligible studies existed for a particular incidence group, incidence data were extrapolated from related groups. Findings A total of 12 eligible studies representing 7 of 10 incidence groups in 24 JE-endemic countries were identified. Approximately 67 900 JE cases typically occur annually (overall incidence: 1.8 per 100 000), of which only about 10% are reported to the World Health Organization. Approximately 33 900 (50%) of these cases occur in China (excluding Taiwan) and approximately 51 000 (75%) occur in children aged 0-14 years (incidence: 5.4 per 100 000). Approximately 55 000 (81%) cases occur in areas with well established or developing JE vaccination programmes, while approximately 12 900 (19%) occur in areas with minimal or no JE vaccination programmes. Conclusion Recent data allowed us to refine the estimate of the global incidence of JE, which remains substantial despite improvements in vaccination coverage. More and better incidence studies in selected countries, particularly China and India, are needed to further refine these estimates.
引用
收藏
页码:766 / 774
页数:9
相关论文
共 45 条
[1]
[Anonymous], 2006, Wkly Epidemiol Rec, V81, P331
[2]
[Anonymous], 1993, MMWR Recomm Rep, V42, P1
[3]
[Anonymous], PATHS JAPANESE ENCEP
[4]
[Anonymous], WORLD FACTB
[5]
[Anonymous], 3 BIR M CONTR JAP EN
[6]
[Anonymous], INFECT AGENTS SURVEI
[7]
[Anonymous], AM J TROP M IN PRESS
[8]
[Anonymous], IMM SURV ASS MON REP
[9]
[Anonymous], CDC HLTH INFORM INT
[10]
[Anonymous], 2010, World Population Prospects: The 2010 Revision